Coronavirus Disease-19 Pandemic and Dermatology. What to Expect?

Authors

  • Vesna Brishkoska-Boshkovski Department of Dermatology, General Hospital “8th September”, Skopje, Republic of Macedonia
  • Mirela Vasileva Department of Dermatology, Clinical Hospital, Shtip, Macedonia
  • Irena Dimitrovska Department of Dermatology, General Hospital “8th September”, Skopje, Republic of Macedonia
  • Vesna Grivcheva-Panovska University Clinic of Dermatology, University Sts Cyril and Methodius, Skopje, Republic of Macedonia

DOI:

https://doi.org/10.3889/oamjms.2020.5032

Keywords:

Coronavirus disease-19 pandemic, Dermatology, Psychodermatological disorders

Abstract

The novel coronavirus (CoV), CoV disease (COVID)-19, and the ongoing pandemic, is changing every aspect of the human life. Furthermore, the COVID-19 pandemic has a profound impact on health-care worldwide, with no exception in dermatology care units. At the time of pandemic, constant fear and stress are present on the surface. Skin diseases are the most common somatic causes of psychological disorders and, conversely. During a stressful situation, the body has power to adjust and to maintain its well-being, but with prolonged exposure to stress, the first negative changes such as fear, anxiety, and depression will eventually lead to chronic fatigue and an increased risk of disease. The proportion of patients reporting emotional triggers varies with the disease, ranging from approximately 50% in acne to 90% in rosacea, alopecia areata, psoriasis, neurotic excoriations, and lichen simplex and may be 100% for patients with hyperhidrosis. In this paper, we will look at the most common psychodermatological disorders and its implication in the era of COVID-19 pandemic. According to all the pathophysiological conditions that indicate the association of skin diseases with stress, it is normal to expect their deterioration and occurrence in this pandemic period. We will be witnessing a growing number in patients’ consultations with chronic urticaria, dermographism, worsening rosacea, generalization, and relapses of psoriasis. It is needed to be prepared for as many cases as possible, because the psychological consequences will still be felt. We encourage more comprehensive studies of the implications of the COVID-19 pandemic in these patients.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Chen Y, Pradhan S, Xue S. What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus? J Am Acad Dermatol. 2020;82(4):1034. https://doi.org/10.1016/j.jaad.2020.02.030 PMid:32081700

Warshaw EM, Hillman YJ, Greer NL, Hagel EM, MacDonald R, Rutks IR, et al. Teledermatology for diagnosis and management of skin conditions: A systematicreview. J Am Acad Dermatol. 2011;64(4):759-72. PMid:21036419

Dermatology Advice Regarding Self-isolation and Immunosuppressed Patients: Adults, Paediatrics and Young People. Healthcare Professionals. British Association of Dermatologists. Available from: https://www. badorguk/healthcare-professionals/covid-19/covid-19- immunosuppressed-patients. [Last accessed on 2020 Apr 14].

COVID-19: Clinical Guidelines for the Management of Dermatology Patients Remotely. Healthcare Professionals British Association of Dermatologists. Available from: https:// www.badorguk/healthcare-professionals/covid-19/remote-dermatology-guidance. [Last accessed on 2020 Jun 17].

Price KN, Frew JW, Hsiao JL, Shi VY. COVID19 and immunomodulator/immunosuppressant use in dermatology. J Am Acad Dermatol. 2020;82:e173-5. PMid:32224277

Statement on the Coronavirus (COVID-19) Outbreak. International Psoriasis Council; 2020. Available from: http:// www.psoriasiscouncil.org. [Last accessed on 2020 Sep 1].

Jakhar D, Kaur I, Kaul S. Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day? J Eur Acad Dermatol Venereol. 2020;34(6):e242-4. https://doi.org/10.1111/jdv.16412 PMid:32223004

Eva MJ. Stressed skin? A molecular psychosomatic update on stress-causes and effects in dermatologic diseases. J Dtsch Dermatol Ges. 2016;14(3):233-52. https://doi.org/10.1111/ddg.12957 PMid:26972185

O’Sullivan RL, Lipper G, Lerner EA. The neuro-immuno-cutaneous-endocrine network: Relationship of mind and skin. Arch Dermatol. 1998;134(11):1431-5. https://doi.org/10.1001/archderm.134.11.1431 PMid:9828880

Martin-Ezquerra G, Man MQ, Hupe M, Rodriguez-Martin M, Youm JK, Trullas C, et al. Psychological stress regulates antimicrobial peptide expression by both glucocorticoid and β-adrenergic mechanisms. Eur J Dermatol. 2011;21(2):48-51. https://doi.org/10.1684/ejd.2011.1273 PMid:21628130

Koo JY, Lee CS. General approach to evaluating psychodermatological disorders. In: Psychocutaneous Medicine. New York: Marcel Dekker, Inc.; 2003. p. 1-29.

Griffiths CE, Richards HL. Psychological influences in psoriasis. Clin Exp Dermatol. 2001;26(4):338-42. https://doi.org/10.1046/j.1365-2230.2001.00834.x PMid:11422186

Arslanagić N, Arslanagić R. Effect of psychological trauma caused by war on manifestations of psoriasis. Med Arh. 2003;57(3):145-7. PMid:12858652

Faulstich ME, Williamson DA, Duchmann EG, Conerly SL, Brantley PJ. Psychophysiological analysis of atopic dermatitis. J Psychosom Res. 1985;29(4):415-7. https://doi.org/10.1016/0022-3999(85)90027-3 PMid:4057129

Willemsen R, Vanderlinden J, Roseeuw D, Haentjens P. Increased history of childhood and lifetime traumatic events among adults with alopecia areata. J Am Acad Dermatol. 2009;60(3):388-93. https://doi.org/10.1016/j.jaad.2008.09.049 PMid:19026463

Díaz-Atienza F, Gurpegui M. Environmental stress but not subjective distress in children or adolescents with alopecia areata. J Psychosom Res. 2011;71(2):102-7. https://doi.org/10.1016/j.jpsychores.2011.01.007 PMid:21767691

Prćić S, Durović D, Duran V, Vuković D, Gajinov Z. Some psychological characteristics of children and adolescents with vitiligo--our results. Med Pregl. 2006;59(5-6):265-9. https://doi.org/10.2298/mpns0606265p PMid:17039911

Buske-Kirschbaum A, Geiben A, Wermke C, Pirke KM, Hellhammer D. Preliminary evidence for herpes labialis recurrence following experimentally induced disgust. Psychother Psychosom. 2001;70(2):86-91. https://doi.org/10.1159/000056231 PMid:11244389

Gupta MA, Gupta AK. Herpes zoster in the medically healthy child and covert severe child abuse. Cutis. 2000;66(3):221-3. PMid:11006859

Garcovich S, Bersani F, Chiricozzi A, De Simone C. Mass quarantine measures in the time of COVID-19 pandemic: Psychosocial implications for chronic skin conditions and a call for qualitative studies. J Eur Acad Dermatol Venereol. 2020;34(7):e293-4. https://doi.org/10.1111/jdv.16535 PMid:32330329

Downloads

Published

2020-09-15

How to Cite

1.
Brishkoska-Boshkovski V, Vasileva M, Dimitrovska I, Grivcheva-Panovska V. Coronavirus Disease-19 Pandemic and Dermatology. What to Expect?. Open Access Maced J Med Sci [Internet]. 2020 Sep. 15 [cited 2024 Apr. 26];8(T1):290-3. Available from: https://oamjms.eu/index.php/mjms/article/view/5032